As of 2024-12-15, the Intrinsic Value of Seelos Therapeutics Inc (SEEL) is 145.46 USD. This SEEL valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.28 USD, the upside of Seelos Therapeutics Inc is 11,263.91%.

	Range	Selected	Upside
a
DCF (Growth 5y)	(2,588,381,463.94) - (302,657,635.90)	(541,129,244.44)	-42275722322.2%
DCF (Growth 10y)	(106,865,939,066,788.09) - (965,898,296,361,392.75)	(196,408,888,888,888.88)	-1.5344444444444544e+16%
DCF (EBITDA 5y)	(117,422,517.17) - (136,744,616.44)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(41,487,230,688,328.60) - (51,062,699,260,217.83)	(1,234.50)	-123450.0%
Fair Value	145.46 - 145.46	145.46	11,263.91%
P/E	593.47 - 761.04	702.56	54787.6%
EV/EBITDA	602.15 - 1,266.19	921.65	71904.0%
EPV	(6,517.28) - (8,719.62)	(7,618.42)	-595288.9%
DDM - Stable	20.24 - 367.25	193.75	15036.5%
DDM - Multi	(1,416,022.31) - (80,236,015.96)	(4,912,789.33)	-383811766.7%